A study for a 72 year old man who takes Eliquis, Amiodarone Hydrochloride (an AI-powered real world drug study)
Summary:
1,660 males aged 72 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 72 year old male patient who has Stroke Secondary To Atrial Fibrillation, Atrial Fibrillation. The study is created by eHealthMe based on reports from sources including the FDA.
1,660 males aged 72 (±5) who take Eliquis, Amiodarone Hydrochloride and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 72
- Gender: male
- Conditions: Stroke Secondary To Atrial Fibrillation, Atrial Fibrillation
- Drugs taken:
- Eliquis (apixaban)
- Amiodarone Hydrochloride (amiodarone hydrochloride)
Comparison with patient's specific adverse outcomes:
You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.
By the same drug(s):
-
Memory Loss:
- among males aged 72 (±5) who take the same drugs: 0.12% (2 of 1,660)
- among people who take the same drugs, regardless of gender or age: 0.02% (2 of 10,967)
By each condition:
-
people who have Memory Loss with Stroke Secondary To Atrial Fibrillation:
- among males aged 72 (±5) who have Stroke Secondary To Atrial Fibrillation: 0% (0 of 0)
- among people who have Stroke Secondary To Atrial Fibrillation, regardless of gender or age: 0% (0 of 0) -
people who have Memory Loss with Atrial Fibrillation:
- among males aged 72 (±5) who have Atrial Fibrillation: 0.44% (172 of 39,159)
- among people who have Atrial Fibrillation, regardless of gender or age: 0.66% (1,488 of 226,254)
By each drug (FDA data only):
-
people who take Eliquis and have Memory Loss:
- among males aged 72 (±5) who take Eliquis and have side effects: 1% (193 of 19,348)
- among people who take Eliquis and have side effects, regardless of gender or age: 1.06% (2,007 of 189,426) -
people who take Amiodarone Hydrochloride and have Memory Loss:
- among males aged 72 (±5) who take Amiodarone Hydrochloride and have side effects: 0.66% (10 of 1,510)
- among people who take Amiodarone Hydrochloride and have side effects, regardless of gender or age: 0.7% (65 of 9,284)
Common drug interactions *:
- Dyspnea (difficult or laboured breathing): 162 people, 9.76%
- Fatigue (feeling of tiredness): 100 people, 6.02%
- Cardiac Failure : 92 people, 5.54%
- Death : 88 people, 5.30%
- Weakness : 87 people, 5.24%
- Dizziness : 82 people, 4.94%
- Hypotension (abnormally low blood pressure): 80 people, 4.82%
- Diarrhea : 74 people, 4.46%
- Pneumonia : 70 people, 4.22%
- Interstitial Lung Disease : 66 people, 3.98%
- Fall : 63 people, 3.80%
- Oedema Peripheral (superficial swelling): 53 people, 3.19%
- Pain : 51 people, 3.07%
- Weight Decreased : 51 people, 3.07%
- Acute Kidney Failure : 49 people, 2.95%
- Nausea (feeling of having an urge to vomit): 49 people, 2.95%
- Drug Ineffective : 49 people, 2.95%
- Cardiac Disorder : 47 people, 2.83%
- Cardiac Failure Congestive : 46 people, 2.77%
- Anaemia (lack of blood): 45 people, 2.71%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 293 people, 17.65%
- High Blood Pressure : 217 people, 13.07%
- Multiple Myeloma (cancer of the plasma cells): 122 people, 7.35%
- Pain : 93 people, 5.60%
- Cardiac Failure : 89 people, 5.36%
- Type 2 Diabetes : 63 people, 3.80%
- High Blood Cholesterol : 58 people, 3.49%
- Cardiac Disorder : 45 people, 2.71%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 40 people, 2.41%
- Diabetes : 38 people, 2.29%
- Dyslipidaemia (abnormal amount of lipids): 37 people, 2.23%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 35 people, 2.11%
- Nausea (feeling of having an urge to vomit): 35 people, 2.11%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 34 people, 2.05%
- Cardiac Failure Chronic : 33 people, 1.99%
- Gout (uric acid crystals building up in the body): 32 people, 1.93%
- Constipation : 32 people, 1.93%
- Cardiac Failure Congestive : 31 people, 1.87%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 30 people, 1.81%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 28 people, 1.69%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Pantoprazole (208 people, 12.53%)
- Furosemide (167 people, 10.06%)
- Metformin (163 people, 9.82%)
- Amlodipine (155 people, 9.34%)
- Tamsulosin (154 people, 9.28%)
- Lasix (131 people, 7.89%)
- Entresto (126 people, 7.59%)
- Lipitor (97 people, 5.84%)
- Clopidogrel (97 people, 5.84%)
- Aspirin (94 people, 5.66%)
- Allopurinol (86 people, 5.18%)
- Prednisone (86 people, 5.18%)
- Coreg (85 people, 5.12%)
- Revlimid (82 people, 4.94%)
- Acetaminophen (79 people, 4.76%)
- Spiriva (77 people, 4.64%)
- Ramipril (71 people, 4.28%)
- Spironolactone (70 people, 4.22%)
- Tylenol (67 people, 4.04%)
- Vitamin D3 (64 people, 3.86%)
Drug effectiveness *:
Eliquis:
- not at all: 0 %
- somewhat: 0 %
- moderate: 0 %
- high: 100 %
- very high: 0 %
Amiodarone Hydrochloride:
- not at all: 0 %
- somewhat: 50 %
- moderate: 0 %
- high: 0 %
- very high: 50 %
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drug side effects in long term, by gender and age:
- Amiodarone hydrochloride: 10,053 reports
- Eliquis: 191,768 reports
Treatments, associated medications and conditions:
- Atrial fibrillation: 349,108 reports
- Memory loss: 244,421 reports
- Stroke secondary to atrial fibrillation: 106 reports
Drug side effects:
- Eliquis and Memory loss (2,007 reports)
- Amiodarone hydrochloride and Memory loss (65 reports)
Drug interactions:
Symptoms:
- Stroke secondary to atrial fibrillation and Memory loss
- Atrial fibrillation and Memory loss (1,488 reports)
Drugs that are associated with:
- Memory loss: 2,786 drugs
Conditions that are associated with:
- Memory loss: 4,339 conditions
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.